Thromb Haemost 2001; 86(02): 529-533
DOI: 10.1055/s-0037-1616081
Review Article
Schattauer GmbH

Diagnostic Accuracy of Compression Ultrasonography for the Detection of Asymptomatic Deep Venous Thrombosis in Medical Patients

The TADEUS Project
Luc Bressollette
1   Department of Internal Medicine and Chest Diseases
,
Michel Nonent
2   Department of Radiology, Hôpital de la Cavale Blanche
,
Emmanuel Oger
1   Department of Internal Medicine and Chest Diseases
,
Jean-François Garcia
3   Service of Radiology, Clermont-Tonnerre Military Hospital, Brest, France
,
Pascal Larroche
2   Department of Radiology, Hôpital de la Cavale Blanche
,
Bruno Guias
1   Department of Internal Medicine and Chest Diseases
,
Pierre-Yves Scarabin
4   INSERM Unit 258, Villejuif, France
,
Dominique Mottier
1   Department of Internal Medicine and Chest Diseases
› Author Affiliations
Further Information

Publication History

Received 17 August 2000

Accepted after resubmission 20 February 2001

Publication Date:
12 December 2017 (online)

Summary

We assessed the accuracy of venous compression ultrasonography (CUS) for the detection of asymptomatic deep vein thrombosis in 122 consecutive patients, with a mean age of 69 years, who were hospitalised in an internal medicine unit. All included patients had CUS within 48 h of admission. Twelve out of 17 patients with a positive CUS underwent phlebography, as the others withdrew their consent, whereas the remaining 105 patients with a negative serial CUS testing were clinically followed-up at 3 months. We found that CUS had a sensitivity and a specificity of respectively 1 (95% CI, 0.73 to 1) and 1 (95% CI, 0.96 to 1) for the detection of asymptomatic deep vein thrombosis. Kappa-coefficients for intra-observer and inter-observer agreements were respectively 0.88 and 0.56. We concluded that venous compression ultrasonography, performed as described, fulfils requirements of a screening test that could be available for prophylactic clinical trials or epidemiological researches.

 
  • References

  • 1 Oger E. for the EPI-GETBO Study Group.. Incidence of venous thromboembolism: a community-based study in western france. Thromb Haemost 2000; 83: 657-60.
  • 2 Clagett GP, Anderson Jr FA, Geerts W, Heit JA, Knudson M, Lieberman JR. et al. Prevention of venous thromboembolism. Chest 1998; 114 (Suppl. 05) 531-60.
  • 3 Couturaud F, Leroyer C, Le Moigne E, Oger E, Mottier D. [Prevention of deep venous thrombosis in medical care] Prevention de la thrombose veineuse profonde en milieu medical. Presse Med 1996; 25 (Suppl. 39) 1935-40.
  • 4 Kalebo P, Ekman S, Lindbratt S, Eriksson BI, Pauli U, Zachrisson BE. et al. Percentage of inadequate phlebograms and observer agreement in thromboprophylactic multicenter trials using standardized methodology and central assessment. Thromb Haemost 1996; 76: 893-6.
  • 5 Lensing AW, Buller HR, Prandoni P, Batchelor D, Molenaar AH, Cogo A. et al. Contrast venography, the gold standard for the diagnosis of deep-vein thrombosis: improvement in observer agreement. Thromb Haemost 1992; 67: 8-12.
  • 6 Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med 1998; 129: 1044-9.
  • 7 Wells PS, Lensing AW, Davidson BL, Prins MH, Hirsh J. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis. Ann Intern Med 1995; 122: 47-53.
  • 8 Kearon C, Julian JA, Newman TE, Ginsberg JS. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med 1998; 128: 663-77.
  • 9 Oger E, Leroyer C, Bressollette L, Nonent M, Le Moigne E, Bizais Y. et al. Evaluation of a new, rapid, and quantitative D-Dimer test in patients with suspected pulmonary embolism. Am J Respir Crit Care Med 1998; 158: 65-70.
  • 10 Harenberg J, Kallenbach B, Martin U, Dempfle CE, Zimmermann R, Kubler W. et al. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients. Thromb Res 1990; 59: 639-50.
  • 11 Manciet G, Vergnes C, Vaissié JJ, Boisseau MR. A study on the efficacy and tolerance of Fraxiparine during long-term therapy in the elderly: a randomized double-blind clinical trial. In: Fraxiparine second international symposium. Recent pharmacological and clinical data. Bounameaux H, Samama MM, TenCate JW. eds. Schattauer, New York: Thromb Haemost; 1990: 55-9.
  • 12 Harenberg J, Roebruck P, Stehle G, Habscheid W, Biegholdt M, Heene DL. Heparin Study in Internal Medicine (HESIM): design and preliminary results. Thromb Res 1992; 68: 33-43.
  • 13 Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C. et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
  • 14 Wille-Jorgensen P, Borris L, Jorgensen LN, Hauch O, Lassen MR, Nehen AM. et al. Phlebography as the gold standard in thromboprophylactic studies? A multicenter interobserver variation study. Acta Radiol 1992; 33: 24-8.
  • 15 Couson F, Bounameaux C, Didier D, Geiser D, Meyerovitz MF, Schmitt HE. et al. Influence of variability of interpretation of contrast venography for screening of postoperative deep venous thrombosis on the results of a thromboprophylactic study. Thromb Haemost 1993; 70: 573-5.
  • 16 Kalodiki E, Nicolaides AN, Al Kutoubi A, Cunningham DA, Mandalia S. How is the standard? Interobservers’ variation on venograms. Int Angiol 1998; 17: 83-8.